Skip to main content
Log in

Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Gastric cancer screening or diagnosis is mainly based on endoscopy and biopsy. The aim of this study was to identify the difference of metabolomic profile between normal and malignant gastric tissue, and to further explore tumor biomarkers. Chemical derivatization together with gas chromatography/mass spectrometry (GC/MS) was utilized to obtain the metabolomic information of the malignant and non-malignant tissues of gastric mucosae in 18 gastric cancer patients. Acquired metabolomic data was analyzed using the Wilcoxon rank sum test to find the tissue metabolic biomarkers for gastric cancer. A diagnostic model for gastric cancer was constructed using principal component analysis (PCA), and was assessed with receiver-operating characteristic (ROC) curves. Results showed that 18 metabolites were detected differently between the malignant tissues and the adjacent non-malignant tissues of gastric mucosa. Five metabolites were also detected differently between the non-invasive tumors and the invasive tumors. The diagnostic model could discriminate tumors from normal mucosae with an area under the curve (AUC) value of 0.9629, and another diagnostic model constructed for clinical staging was assessed with an AUC value of 0.969. We conclude that the metabolomic profile of malignant gastric tissue was different from normal, and that the selected tissue metabolites could probably be applied for clinical diagnosis or staging for gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  Google Scholar 

  2. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362

    Google Scholar 

  3. Macdonald JS (2006) Gastric cancer—new therapeutic options. N Engl J Med 355:76–77

    Article  CAS  Google Scholar 

  4. Cunningham D, Chua YJ (2007) East meets west in the treatment of gastric cancer. N Engl J Med 357:1863–1865

    Article  CAS  Google Scholar 

  5. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8:86–94

    Article  CAS  Google Scholar 

  6. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y (2006) Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol 12:4873–4874

    Google Scholar 

  7. Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, Suovaniemi O, Alanko A, Harkonen M (2002) Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 37:785–791

    CAS  Google Scholar 

  8. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila A, Sipponen P (2003) Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 15:885–891

    Article  CAS  Google Scholar 

  9. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98:735–739

    Article  Google Scholar 

  10. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA (1999) Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 44:693–697

    Article  CAS  Google Scholar 

  11. Kikuchi S, Kurosawa M, Sakiyama T, Tenjin H, Miki K, Wada O, Inaba Y (2000) Long-term effect of Helicobacter pylori infection on serum pepsinogens. Jpn J Cancer Res 91:471–476

    CAS  Google Scholar 

  12. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9:279–287

    Article  Google Scholar 

  13. Mal M, Koh PK, Cheah PY, Chan EC (2009) Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun Mass Spectrom 23:487–494

    Article  CAS  Google Scholar 

  14. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90, 000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11:369–376

    Google Scholar 

  15. Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A (2007) Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 25:2840–2846

    Article  CAS  Google Scholar 

  16. Wikoff WR, Gangoiti JA, Barshop BA, Siuzdak G (2007) Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 53:2169–2176

    Article  CAS  Google Scholar 

  17. Deng C, Li N, Zhang X (2004) Development of headspace solid-phase microextraction with on-fiber derivatization for determination of hexanal and heptanal in human blood. J Chromatogr B Analyt Technol Biomed Life Sci 813:47–52

    Article  CAS  Google Scholar 

  18. Xue R, Lin Z, Deng C, Dong L, Liu T, Wang J, Shen X (2008) A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 22:3061–3068

    Article  CAS  Google Scholar 

  19. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS, Flint Beal M (2008) Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131:389–396

    Article  Google Scholar 

  20. Chen J, Zhao X, Fritsche J, Yin P, Schmitt-Kopplin P, Wang W, Lu X, Haring HU, Schleicher ED, Lehmann R, Xu G (2008) Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal Chem 80:1280–1289

    Article  CAS  Google Scholar 

  21. Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X (2009) Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:3111–3117

    Article  CAS  Google Scholar 

  22. Deng C, Zhang X, Li N (2004) Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 808:269–277

    Article  CAS  Google Scholar 

  23. Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161

    Article  CAS  Google Scholar 

  24. Jonsson P, Gullberg J, Nordstrom A, Kusano M, Kowalczyk M, Sjostrom M, Moritz T (2004) A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal Chem 76:1738–1745

    Article  CAS  Google Scholar 

  25. Jonsson P, Johansson AI, Gullberg J, Trygg J, Jiye A, Grung B, Marklund S, Sjostrom M, Antti H, Moritz T (2005) High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 77:5635–5642

    Article  CAS  Google Scholar 

  26. Deng C, Zhang J, Yu X, Zhang W, Zhang X (2004) Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 810:269–275

    CAS  Google Scholar 

  27. Sobin LH, Fleming ID (1997) TNM Classification of Malignant Tumors, 5th edn (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80:1803–1804

    Article  CAS  Google Scholar 

  28. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8:352–361

    Article  CAS  Google Scholar 

  29. Lin CY, Wu HF, Tjeerdema RS, Viant MR (2007) Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3:55–67

    Article  CAS  Google Scholar 

  30. Kim HK, Choi YH, Luijendijk TJ, Rocha RA, Verpoorte R (2004) Comparison of extraction methods for secologanin and the quantitative analysis of secologanin from Symphoricarpos albus using 1H-NMR. Phytochem Anal 15:257–261

    Article  CAS  Google Scholar 

  31. Xue R, Dong L, Wu H, Liu T, Wang J, Shen X (2009) Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med 47:305–310

    Article  CAS  Google Scholar 

  32. Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, Shen X (2009) Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta 648:98–104

    Article  CAS  Google Scholar 

  33. Jonsson P, Bruce SJ, Moritz T, Trygg J, Sjostrom M, Plumb R, Granger J, Maibaum E, Nicholson JK, Holmes E, Antti H (2005) Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst 130:701–707

    Article  CAS  Google Scholar 

  34. Trygg J, Holmes E, Lundstedt T (2007) Chemometrics in metabonomics. J Proteome Res 6:469–479

    Article  CAS  Google Scholar 

  35. Postic C, Dentin R, Girard J (2004) Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30:398–408

    Article  CAS  Google Scholar 

  36. Anthony ML, Rose VS, Nicholson JK, Lindon JC (1995) Classification of toxin-induced changes in 1H NMR spectra of urine using an artificial neural network. J Pharm Biomed Anal 13:205–211

    Article  CAS  Google Scholar 

  37. Beckonert O, Bollard ME, Ebbels TMD, Keun HC, Antti H, Holmes E, Lindon JC, Nicholson JK (2003) Anal Chim Acta 490:3

    Article  CAS  Google Scholar 

  38. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69:4918–4925

    Article  CAS  Google Scholar 

  39. Taniguchi K, Nonami T, Nakao A, Harada A, Kurokawa T, Sugiyama S, Fujitsuka N, Shimomura Y, Hutson SM, Harris RA, Takagi H (1996) The valine catabolic pathway in human liver: effect of cirrhosis on enzyme activities. Hepatology 24:1395–1398

    Article  CAS  Google Scholar 

  40. Ishigure K, Shimomura Y, Murakami T, Kaneko T, Takeda S, Inoue S, Nomoto S, Koshikawa K, Nonami T, Nakao A (2001) Human liver disease decreases methacrylyl-CoA hydratase and beta-hydroxyisobutyryl-CoA hydrolase activities in valine catabolism. Clin Chim Acta 312:115–121

    Article  CAS  Google Scholar 

  41. Landel AM, Hammond WG, Meguid MM (1985) Aspects of amino acid and protein metabolism in cancer-bearing states. Cancer 55:230–237

    Article  CAS  Google Scholar 

  42. Wu H, Zhang X, Li X, Wu Y, Pei F (2005) Acute biochemical effects of La(NO3)3 on liver and kidney tissues by magic-angle spinning 1H nuclear magnetic resonance spectroscopy and pattern recognition. Anal Biochem 339:242–248

    Article  CAS  Google Scholar 

  43. Waters NJ, Holmes E, Waterfield CJ, Farrant RD, Nicholson JK (2002) NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochem Pharmacol 64:67–77

    Article  CAS  Google Scholar 

  44. Yang Y, Li C, Nie X, Feng X, Chen W, Yue Y, Tang H, Deng F (2007) Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 6:2605–2614

    Article  CAS  Google Scholar 

  45. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, Wu YC, Chen WJ, Yu CJ, Lin SR, Lin KH (2008) Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 123:1787–1796

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was financially supported by National Basic Research Program of China (2007CB936000), Ministry of Health (2009ZX10004-301), China National Key Projects for Infectious Diseases (2008ZX10002-017) and National Nature Science Foundation of China (No. 30772505 and No. 30872503).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yihong Sun or Xizhong Shen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, H., Xue, R., Tang, Z. et al. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem 396, 1385–1395 (2010). https://doi.org/10.1007/s00216-009-3317-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-009-3317-4

Keywords

Navigation